Named on 3 rounds in the feed, most often at Series D+ and in Medtech.
Rounds from 2021-07-15 to 2026-09-01
ROUNDS
3
joined, none as lead
ROUNDS JOINED · USD
$292M
2 of 3 rounds state an amount
CO-INVESTORS
15
named beside it
Named on 3 rounds in the feed, most often at Series D+ and in Medtech.
Rounds from 2021-07-15 to 2026-09-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
N-Power Medicine A biotech infrastructure company for oncology trials | Series B Verified against 3 sources | $32M | 2026-09-01 | [ PART ] |
Imperative Care Medical devices and technologies for treating strokes and vascular diseases. | Series D+ Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | up to $150M financing total | 2024-07-25 | [ PART ] |
Imperative Care Medical devices and technologies for treating strokes and vascular diseases. | Series D+ Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $260M | 2021-07-15 | [ PART ] |